Market Highlights hydrate inhibitors market was valued at USD 180.3 Million in 2018 and is projected to register a CAGR of 7.70% during the forecast period. The advantages of low-dosage hydrate inhibitors (LDHI) such cost-effectiveness due to requirement of less transportation, storage, and maintenance costs; and effective during extended shut-ins and in low volumes are boosting the growth of...